TScan Therapeutics, Inc.
NASDAQ:TCRX
4.75 (USD) • At close October 29, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | 2019 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||||
Current Assets: | |||||||||||||||||
Cash & Cash Equivalents
| 242.159 | 140.513 | 133.359 | 155.193 | 208.842 | 95.608 | 120.027 | 137.306 | 125.603 | 140.838 | 161.405 | 182.312 | 106.197 | 121.501 | 34.791 | -41.764 | 5.89 |
Short Term Investments
| 55.517 | 22.27 | 58.685 | 60.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 83.528 | 0 |
Cash and Short Term Investments
| 297.676 | 162.783 | 192.044 | 155.193 | 208.842 | 95.608 | 120.027 | 137.306 | 125.603 | 140.838 | 161.405 | 182.312 | 106.197 | 121.501 | 34.791 | 41.764 | 5.89 |
Net Receivables
| 0 | 0 | 0 | 0 | 31.926 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.316 | 0 |
Inventory
| 0 | 0 | 0 | 0 | -33.376 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 1.854 | 1.938 | 2.193 | 2.144 | 1.45 | 5.299 | 4.1 | 3.871 | 3.757 | 4.911 | 4.249 | 4.691 | 3.873 | 2.372 | 1.654 | -4.316 | 0 |
Total Current Assets
| 299.53 | 164.721 | 194.237 | 155.193 | 208.842 | 95.608 | 120.027 | 141.177 | 129.36 | 145.749 | 165.654 | 187.003 | 110.07 | 123.873 | 36.445 | 41.764 | 5.89 |
Non-Current Assets: | |||||||||||||||||
Property, Plant & Equipment, Net
| 68.564 | 69.433 | 71.234 | 67.134 | 68.027 | 66.933 | 69.202 | 14.702 | 15.553 | 15.814 | 17.256 | 17.125 | 16.636 | 15.183 | 12.532 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 5.031 | 5.031 | 5.031 | 5.031 | 5.031 | 5.031 | 5.037 | 0 | 5.037 | 5.031 | 5.197 | 0.595 | 0.595 | 0.761 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.315 | 0 |
Other Non-Current Assets
| 1.746 | 1.647 | 1.647 | 64.021 | 35.023 | 6.005 | 4.825 | 9.575 | 2.465 | 1.61 | 0 | 0.166 | 2.706 | 1.123 | 0.761 | -44.079 | 0 |
Total Non-Current Assets
| 75.341 | 76.111 | 77.912 | 136.186 | 108.081 | 77.969 | 79.064 | 24.277 | 23.055 | 22.455 | 22.453 | 17.886 | 19.937 | 17.067 | 13.293 | -41.764 | 0 |
Total Assets
| 374.871 | 240.832 | 272.149 | 291.379 | 316.923 | 173.577 | 199.091 | 165.454 | 152.415 | 168.204 | 188.107 | 204.889 | 130.007 | 140.94 | 49.738 | 351.784 | 411.898 |
Liabilities & Equity: | |||||||||||||||||
Current Liabilities: | |||||||||||||||||
Account Payables
| 3.11 | 2.123 | 2.374 | 3.196 | 3.394 | 2.773 | 2.912 | 2.708 | 3.096 | 2.886 | 1.765 | 5.072 | 3.547 | 3.574 | 2.91 | 0 | 0 |
Short Term Debt
| 13.95 | 10.135 | 6.593 | 5.486 | 4.209 | 3.836 | 3.681 | 1.795 | 1.746 | 1.698 | 1.651 | 1.62 | 1.575 | 1.53 | 1.415 | 109.067 | 108.866 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 10.704 | 10.435 | 10.137 | 15.212 | 19.211 | 0 | 3.874 | 5.932 | 8.17 | 10.869 | 11.41 | 11.967 | 11.746 | 11.382 | 10.627 | 0 | 0 |
Other Current Liabilities
| 10.808 | 8.786 | 10.716 | 9.257 | 8.304 | 7.438 | 6.838 | 6.159 | 4.158 | 3.012 | 6.517 | 4.285 | 3.749 | 2.352 | 2.494 | 0 | 0 |
Total Current Liabilities
| 38.572 | 31.479 | 29.82 | 33.151 | 35.118 | 14.047 | 17.305 | 16.594 | 17.17 | 18.465 | 21.343 | 22.944 | 20.617 | 18.838 | 17.446 | 109.067 | 108.866 |
Non-Current Liabilities: | |||||||||||||||||
Long Term Debt
| 20.112 | 23.449 | 26.7 | 81.497 | 83.53 | 81.476 | 82.303 | 32.105 | 3.496 | 3.948 | 4.392 | 4.791 | 5.211 | 5.619 | 6.019 | 0 | 0 |
Deferred Revenue Non-Current
| 3.955 | 4.758 | 5.622 | 7.758 | 7.644 | 0 | 0 | 0 | 0 | 0 | 1.497 | 2.844 | 4.56 | 6.756 | 8.816 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 53.421 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 159.411 | 159.411 | 59.681 | 1.505 | 0 |
Other Non-Current Liabilities
| 57.011 | 4.758 | 59.14 | 0.012 | 0.024 | 0.036 | 0.049 | 0.097 | 0.097 | 0.097 | 0.097 | 0.236 | 0.238 | 0.238 | 0.238 | 107.562 | 108.866 |
Total Non-Current Liabilities
| 81.078 | 86.386 | 91.462 | 89.267 | 91.198 | 81.512 | 82.352 | 32.202 | 3.593 | 4.045 | 5.986 | 7.871 | 169.42 | 172.024 | 74.754 | 109.067 | 108.866 |
Total Liabilities
| 119.65 | 117.865 | 121.282 | 122.418 | 126.316 | 95.559 | 99.657 | 48.796 | 20.763 | 22.51 | 27.329 | 30.815 | 190.037 | 190.862 | 92.2 | 196.879 | 182.443 |
Equity: | |||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 204.889 | 159.411 | 159.411 | 59.681 | 59.681 | 0 |
Common Stock
| 0.006 | 0.005 | 0.005 | 0.005 | 0.005 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.001 | 0.001 | 0.001 | 0.03 | 0.03 |
Retained Earnings
| -309.4 | -277.739 | -247.597 | -227.984 | -204.987 | -180.942 | -158.379 | -139.656 | -123.411 | -108.314 | -92.158 | -77.958 | -62.119 | -51.445 | -43.533 | -154.905 | 0 |
Accumulated Other Comprehensive Income/Loss
| 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -204.889 | -159.411 | 0 | -59.681 | -17.138 | 0 |
Other Total Stockholders Equity
| 564.615 | 400.701 | 398.459 | 396.94 | 395.589 | 258.957 | 257.81 | 256.311 | 255.06 | 254.005 | 252.933 | 252.029 | 2.088 | -157.889 | -58.611 | -0.03 | -0.03 |
Total Shareholders Equity
| 255.221 | 122.967 | 150.867 | 168.961 | 190.607 | 78.018 | 99.434 | 116.658 | 131.652 | 145.694 | 160.778 | 174.074 | -60.03 | -49.922 | -42.462 | 42.543 | 0.03 |
Total Equity
| 255.221 | 122.967 | 150.867 | 168.961 | 190.607 | 78.018 | 99.434 | 116.658 | 131.652 | 145.694 | 160.778 | 174.074 | -60.03 | -49.922 | -42.462 | 42.543 | 0.03 |
Total Liabilities & Shareholders Equity
| 374.871 | 240.832 | 272.149 | 291.379 | 316.923 | 173.577 | 199.091 | 165.454 | 152.415 | 168.204 | 188.107 | 204.889 | 130.007 | 140.94 | 49.738 | 42.543 | 411.898 |